Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what his planned timeline is for the publication of an assessment of the (a) efficacy and (b) impact of the maternal vaccination programme for respiratory syncytial virus.

The UK Health Security Agency undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines. Monitoring and evaluation work has begun for the new respiratory syncytial virus programmes which launched in September 2024 to protect infants through maternal vaccination and for direct protection of older adults. Findings will be published in due course.